Hyperion Defi Inc (HYPD) Stock Price, Quote & News

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology

Sector: Healthcare

Phone: 917 289 1117

Website: hyperiondefi.com

Address:

295 Madison Avenue, Suite 2400, New York, United States

Jwa68 Jan. 13 at 4:33 PM

$HYPD https://x.com/i/status/2011087086414360897

1 · Reply

Pomer_Gile1 Jan. 13 at 12:59 PM

$HYPD Did they get the Optejet approved yet?

1 · Reply

Jwelz90 Jan. 13 at 12:30 PM

$HYPD When you check the short interest, borrow fees, and days to cover of $HYPD. Then remember that insiders own like 30% to make it even more dire for shorts.

0 · Reply

Jwa68 Jan. 13 at 12:18 AM

$HYPD Hope people interested here took the time to rewd this letter from the Ceo. Really well done.

0 · Reply

BullTradeFinder Jan. 12 at 8:09 PM

$HYPD HAD NEWS THIS MORNING! Keep this on watch. https://elite.finviz.com/news/273358/hyperion-defi-issues-letter-to-shareholders Communicated-Disclaimer https://stockresearchtoday.com/brizy-12569/

0 · Reply

MadMaverick Jan. 12 at 7:46 PM

So $HYPD owns a big pile of HYPE tokens — the coin from Hyperliquid, this is a super-fast crypto trading platform that's blowing up with billions in real trades & fees. So if Hyperliquid keeps growing, HYPE price usually goes up → HYPD shareholders win indirectly. One to Watch down here! $HYPD $COIN $HIVE $CRCL

0 · Reply

BeeDecay Jan. 12 at 6:46 PM

$HYPD

0 · Reply

Zaksab Jan. 12 at 6:30 PM

$HYPD not a fan of wordy shareholder letters. "The best is yet to come". I should fucking hope so ...

0 · Reply

jcooptechit Jan. 12 at 4:13 PM

$HYPD Hyunsu Jung appointed CEO (effective Jan 5, 2026). Promoted from CIO, preserving full continuity + accelerating execution. Why this matters: • Crypto-native + institutional pedigree • Portfolio Manager at DARMA Capital (crypto asset mgmt.) • Finance + digital transformation at EY-Parthenon Exactly what Hyperion needs to SCALE: • On-chain business line expansion • Stronger institutional relationships • Operational discipline • Monetizing growth inside the Hyperliquid ecosystem Hyperion is stacking elite leadership to build the #1 public-market gateway into Hyperliquid + $HYPE. Communicated - Disclaimer: https://chartingdaily.com/creative-design-platform

1 · Reply

kiwitc2000 Jan. 12 at 3:58 PM

$HYPD The shorting continues. Holding. This can only end one of two ways, big cheers or big tears. I'm betting on the bullish outcome short term, but I'd say it's a 50/50 though.

0 · Reply

Hyperion DeFi, Inc. (HYPD) Q3 2025 Earnings Call Transcript

Sep 29, 2025, 8:00 AM EDT - 3 months ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 27, 2025, 7:30 AM EDT - 3 months ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Sep 25, 2025, 8:00 AM EDT - 3 months ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 16, 2025, 8:00 AM EDT - 4 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Aug 14, 2025, 10:16 AM EDT - 5 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 13, 2025, 4:01 PM EDT - 5 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 8, 2025, 4:05 PM EDT - 5 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Jul 28, 2025, 8:00 AM EDT - 6 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 17, 2025, 8:00 AM EDT - 6 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 14, 2025, 4:05 PM EDT - 6 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jun 18, 2025, 2:04 PM EDT - 7 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Jun 18, 2025, 8:32 AM EDT - 7 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 17, 2025, 3:54 PM EDT - 7 months ago

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 2:55 PM EDT - 7 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

May 19, 2025, 5:30 PM EDT - 8 months ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Apr 10, 2025, 7:00 AM EDT - 9 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Mar 20, 2025, 7:00 AM EDT - 10 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Feb 26, 2025, 7:00 AM EST - 11 months ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 24, 2025, 7:00 AM EST - 11 months ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 5, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Jan 28, 2025, 4:05 PM EST - 1 year ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 15, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 6, 2025, 7:00 AM EST - 1 year ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 12, 2024, 10:42 PM EST - 1 year ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Aug 12, 2024, 11:07 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

Jwa68 Jan. 13 at 4:33 PM

$HYPD https://x.com/i/status/2011087086414360897

1 · Reply

Pomer_Gile1 Jan. 13 at 12:59 PM

$HYPD Did they get the Optejet approved yet?

1 · Reply

Jwelz90 Jan. 13 at 12:30 PM

$HYPD When you check the short interest, borrow fees, and days to cover of $HYPD. Then remember that insiders own like 30% to make it even more dire for shorts.

0 · Reply

Jwa68 Jan. 13 at 12:18 AM

$HYPD Hope people interested here took the time to rewd this letter from the Ceo. Really well done.

0 · Reply

BullTradeFinder Jan. 12 at 8:09 PM

$HYPD HAD NEWS THIS MORNING! Keep this on watch. https://elite.finviz.com/news/273358/hyperion-defi-issues-letter-to-shareholders Communicated-Disclaimer https://stockresearchtoday.com/brizy-12569/

0 · Reply

MadMaverick Jan. 12 at 7:46 PM

0 · Reply

BeeDecay Jan. 12 at 6:46 PM

$HYPD

0 · Reply

Zaksab Jan. 12 at 6:30 PM

$HYPD not a fan of wordy shareholder letters. "The best is yet to come". I should fucking hope so ...

0 · Reply

jcooptechit Jan. 12 at 4:13 PM

1 · Reply

kiwitc2000 Jan. 12 at 3:58 PM

$HYPD The shorting continues. Holding. This can only end one of two ways, big cheers or big tears. I'm betting on the bullish outcome short term, but I'd say it's a 50/50 though.

0 · Reply

MadMaverick Jan. 12 at 3:42 PM

MORE TO COME FOR $HYPD 👇🏻 🚨 $HYPD is becoming one of the most explosive public‑market plays tied to the Hyperliquid ecosystem! 🔹Direct exposure to one of the fastest‑growing DeFi infrastructures on the planet 🔹Building a strategic treasury of HYPE, giving shareholders access to real ecosystem value 🔹Hyperliquid continues to post massive on‑chain activity with billions in trading volume 🔹Positioned as a pure‑play proxy for a blockchain generating serious revenue and user growth Why $HYPD stands out: 🔸Most crypto equities chase narratives, $HYPD is tied to a chain with real fees, real users, and real traction 🔸No mining, no hardware, no middlemen, just direct alignment with a high‑performance blockchain ecosystem 🔸A unique public‑market gateway to Hyperliquid’s momentum as the ecosystem expands Communicated Disclaimer - https://chartingdaily.com/creative-design-platform $COIN $HIVE $CRCL

0 · Reply

TheRealShortSqueezy Jan. 12 at 3:32 PM

$HYPD : Powering the Hyperliquid Ecosystem 🌏 Hyperion DeFi is the first listed public company built natively around Hyperliquid, deploying a strategic HYPE treasury across staking, infrastructure, and revenue-generating DeFi partnerships. Today, the company released a shareholder letter from new CEO Hyunsu Jung, highlighting strong 2025 execution and a focused 2026 roadmap. 🔹 Pivoted from biotech to DeFi in June 2025 🔹 Created the first institutional liquid staking token: HiHYPE 🔹 Allocated HYPE to Native Markets to support the USDH stablecoin 🔹 Reported record Q3 2025 net income of $6.6M 🔹 Hyperliquid ranked among the highest-revenue blockchains 🔹 Chardan Capital initiated coverage with a Buy rating, $7.75 price target As tokenization accelerates, Hyperion DeFi is positioned for asymmetric upside as a core operator within a rapidly scaling blockchain ecosystem. 💰📈 Communicated Disclaimer: https://stockresearchtoday.com/brizy-12569/ Sector Peers: $MSTR $MARA $RIOT $COIN

1 · Reply

The_Titan_Traders Jan. 12 at 3:32 PM

$HYPD HYPD – Small Bullish Thesis • Low-cap / thin float setup: HYPD trades at a very small market cap, meaning any meaningful volume or catalyst can move the stock fast. • Speculative momentum appeal: The ticker fits the profile retail traders look for—cheap share price, low liquidity, and high volatility upside. • Asymmetric risk/reward: Downside is largely defined at current depressed levels, while upside can be multiples on news, filings, or renewed attention. • Sentiment-driven potential: Stocks like HYPD don’t need fundamentals to run—momentum + attention alone can trigger sharp spikes. • Crowded micro-cap space favors rotations: When money rotates into small caps, names like HYPD often move late but move hard. Communicated-Disclaimer: https://stockresearchtoday.com/brizy-12569/

0 · Reply

JTE_Theta Jan. 12 at 2:30 PM

🚨 $HYPD DeFi Exposure - One Ticker 🚨 Hyperion DeFi gives investors exposure to DeFi through a NASDAQ listed stock ! No wallets, no custody, no on chain learning curve. With a tight $5M float and a strategic treasury HYPD offers indirect exposure to Hyperliquid, one of the fastest growing, high revenue DeFi ecosystems. Why watch $HYPD ? • Tight float with elevated short interest • Operating company (not ETF/fund) • Strategic treasury tied to HYPD • Staking linked yield + token buybacks • Early stage setup with asymmetric upside CommunicatedDisclaimer:http://stockresearchtoday.com/brizy-12569/

0 · Reply

ZTRADEZ_LLC Jan. 12 at 2:29 PM

Watching This One! (NASDAQ: $HYPD) ✍️Technical Analysis: ✅Volume gap fill $8.53 ✅Trendline hold ✅Open MACD ✅Rising RSI Hyperliquid operates a high-volume on-chain derivatives platform and has quickly risen to the top in daily fee generation, now ranking among the largest cryptocurrencies by market cap. The protocol uses a fixed token supply, staking yield, and a continuous buyback structure that routes most revenue back into the ecosystem. Rising trading volume, fees, and open interest point to growing adoption, with technicals showing the asset holding a trendline and Rising RSI. Communicated Disclaimer https://chartingdaily.com/creative-design-platform

1 · Reply

Jwa68 Jan. 12 at 1:40 PM

$HYPD Excellent shareholder letter just issued. One of the better ones I have seen in over 20 years of advising corporate management. When crypto sees its inevitable resurgence, this is one to watch. https://ir.hyperiondefi.com/news-events/press-releases/detail/302/hyperion-defi-issues-letter-to-shareholders

0 · Reply

Mike827 Jan. 12 at 5:36 AM

$HYPD this little Asian crypto kid ceo is being completely suckered by wall stree. he‘ll see in due time when they dilute shares here the hype coin will deteriorate away in value from exposure to a failure treasury. whatch and see

0 · Reply

Mike827 Jan. 12 at 5:11 AM

$HYPD FAILURE!!!! Complete company failure on display here.😂🤣 coming out with massive dilution of shares when the share price is $3.00 a share is basically telegraphing failure on a epic scale🤷🏿‍♀️🤷🏿‍♀️🤦🏿‍♀️😂😂😂😂

0 · Reply

Mike827 Jan. 12 at 4:55 AM

$HYPD this stock will never ever get above $5.00 a share because management will just keep diluting shares to keep the price low and pay themselves then repeat dilution saying they have to because the share price is low😂😂😂🤣🤣🤣🤣 SCAMMERS!!!!!

0 · Reply

Mike827 Jan. 12 at 4:50 AM

$HYPD it’s clear this company is nothing but a scam failure right from the start. look at what they’re doing!!! They have only been on the Nasdaq for a short period of time and they’re already on their knees groveling for share dilution🤣😂

0 · Reply

Mike827 Jan. 12 at 4:40 AM

$HYPD so management here has no SEC fillings to indicate what the company is doing or about current company activities? Instead just SEC fillings showing insider purchases being reimbursed by massive dilution SEC filings 🤣😂🤣🤦🏿‍♀️🤦🏿‍♀️🤦🏿‍♀️🤦🏿‍♀️

0 · Reply

Mike827 Jan. 12 at 4:36 AM

$HYPD why in the world would you have SEC fillings showing insider purchases and then follow it up with a SEC filling authorizing massive dilution 🤷🏿‍♀️🤣😂🤣 these guys are the biggest booger eaters I’ve ever seen!🤦🏿‍♀️

0 · Reply

Market Cap	28.36M
Revenue (ttm)	60,000.00
Net Income (ttm)	-49.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	1.07
Profit Margin	-83,033.33%
Debt to Equity Ratio	0.11

Volume	301,200
Avg Vol	315,852
Day's Range	N/A - N/A
Shares Out	8.17M
Stochastic %K	20%
Beta	2.69
Analysts	Strong Sell
Price Target	$5.88